Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Acadia Pharmaceuticals (ACAD) Q1 2016 Earnings
ACAD
+2.54%
29
Feb
Confirmed
Q2 2015
Q3 2015
Q4 2015
Q1 2016
-0.45
-0.39
-0.34
-0.28
Details
Expected EPS
-0.38
Actual EPS
-0.45
Surprise EPS
-0.07
Surprise Percent
+18.42%
Description
Acadia Pharmaceuticals (ACAD) has reported earnings of -0.45 per share for Q1 2016.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login